Zhengye Biotechnology Holding Limited Ordinary Shares Cash Flow Reinvestment Rate
Zhengye Biotechnology Holding Limited Ordinary Shares cash flow reinvestment rate. Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Cash Flow Reinvestment Rate of 0.68x as of December 2025, reinvesting $27.77 Million (capex $27.77 Million ) from operating cash flow of $41.05 Million. Explore ZYBT operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Cash flow reinvestment rate of Zhengye Biotechnology Holding Limited Ordinary Shares from 2021 to 2025. Historical reinvestment intensity for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. Explore Zhengye Biotechnology Holding Limited Or (ZYBT) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Zhengye Biotechnology Holding Limited Ordinary Shares Cash Flow Reinvestment Rate by Year (2021–2025)
Zhengye Biotechnology Holding Limited Ordinary Shares cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for Zhengye Biotechnology Holding Limited Ordinary Shares. For the full cash flow conversion analysis, see how efficiently does Zhengye Biotechnology Holding Limited Or generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | $27.77 Million | $41.05 Million | $27.77 Million | ▲ +0.0% |
| 2024 | 0.68x | $27.77 Million | $41.05 Million | $27.77 Million | ▲ +39.5% |
| 2023 | 0.48x | $23.36 Million | $48.18 Million | $11.60 Million | ▼ -84.6% |
| 2022 | 3.15x | $54.66 Million | $17.34 Million | $27.33 Million | ▲ +90.4% |
| 2021 | 1.66x | $52.67 Million | $31.81 Million | $26.40 Million | — |